☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Interview: In Conversation with Pyxis’ CMO Jay M. Feingold, Where he Shares Insights on the addition of In-Licensed &...
May 31, 2022
Innodem Neurosciences’ ETNA Device Receives the US FDA’s Breakthrough Device Designation for the Treatment of Multiple Sclerosis
May 31, 2022
Eledon Reports Results of Tegoprubart in P-IIa Trial Demonstrated Safety, Target Engagement, and Biomarker Response for ALS
May 31, 2022
Regeneron & Sanofi Report the US FDA Acceptance of sBLA for Priority Review of Dupixent (dupilumab) to Treat Prurigo Nodularis
May 31, 2022
Amneal & Kashiv Receive the US FDA’s Approval for Fylnetra (biosimilar, pegfilgrastim)
May 31, 2022
Sandoz Launches New Global ‘Act4Biosmilars’ Initiative to Increase the Biosimilar Adoption Worldwide
May 31, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions